Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 251
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02614456 | Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors | ||
| NCT01068769 | Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor | ||
| NCT05365893 | PHL Treatment in Pancreatic Cancer | ||
| NCT06439706 | HPV Self-sampling for Underscreened Latinas | ||
| NCT00002510 | Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | ||
| NCT02755272 | A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer | ||
| NCT00005021 | Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma | ||
| NCT01739439 | Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery | ||
| NCT00066677 | Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer | ||
| NCT00653146 | The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia | ||
| NCT00021307 | Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme | ||
| NCT02211430 | Smoking Cessation for Low-Income Pregnant Women | ||
| NCT02050009 | Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | ||
| NCT00782834 | Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST) | ||
| NCT00352638 | Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer | ||
| NCT05636943 | Couples' QOL in Metastatic Breast Cancer | ||
| NCT02147080 | A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults | ||
| NCT00054392 | Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | ||
| NCT00021320 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | ||
| NCT05263050 | Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors | ||
| NCT01183559 | A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery | ||
| NCT02442323 | A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients | ||
| NCT07043972 | Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma | ||
| NCT04452357 | Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer | ||
| NCT00084539 | Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer | ||
| NCT02447887 | Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC) | ||
| NCT04618809 | Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer | ||
| NCT04379999 | Atorvastatin ± Aspirin in Lynch Syndrome Syndrome | ||
| NCT00365508 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | ||
| NCT02247115 | Rapid Assessment of Trainee Endoscopy Skills (RATES) Study | ||
| NCT02871752 | Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education | ||
| NCT07221942 | Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma | ||
| NCT00322296 | Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis | ||
| NCT05359952 | Women's Health Communication Study | ||
| NCT02609230 | A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma | ||
| NCT03179995 | Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy | ||
| NCT03094884 | Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer | ||
| NCT01962948 | Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | ||
| NCT00041353 | Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer | ||
| NCT04506554 | A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer | ||
| NCT05062720 | Local Consolidative Therapy in Colorectal Cancer | ||
| NCT04441749 | nCLE For Diagnosis Of Peripheral Lung Nodules By Robotic Navigational Bronchoscopy | ||
| NCT03302247 | Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy | ||
| NCT01031420 | Dose Dense MVAC for Muscle Invasive Bladder Cancer | ||
| NCT02614859 | Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients | ||
| NCT04055753 | Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma | ||
| NCT01637194 | Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer | ||
| NCT03760471 | Palliative and Oncology Care Intervention: Symptom COACH | ||
| NCT01212822 | Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer | ||
| NCT00003944 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
